Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma.
Aziz, Omer Jaradat, Ihab Chakrabarty, Bipasha Selvasekar, Chelliah Fulford, Paul E Saunders, Mark P Renehan, Andrew G Wilson, Malcolm S O'Dwyer, Sarah T
Aziz, Omer
Jaradat, Ihab
Chakrabarty, Bipasha
Selvasekar, Chelliah
Fulford, Paul E
Saunders, Mark P
Renehan, Andrew G
Wilson, Malcolm S
O'Dwyer, Sarah T
Citations
Altmetric:
Abstract
Appendix adenocarcinomas are rare tumors with propensity for peritoneal metastasis. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is an established treatment with curative intent, but, to date, studies reporting survival have been heterogeneous with regard to their patient groups (including other tumor types), interventions (not all patients receiving intraperitoneal chemotherapy), and follow-up (varying surveillance protocols).
Description
Date
2018-07
Publisher
Collections
Keywords
Type
Article
Citation
Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma. 2018, 61 (7):795-802 Dis. Colon Rectum